| Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial GU Meduri, AS Headley, E Golden, SJ Carson, RA Umberger, T Kelso, ... Jama 280 (2), 159-165, 1998 | 1282 | 1998 |
| Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time GU Meduri, S Headley, G Kohler, F Stentz, E Tolley, R Umberger, ... Chest 107 (4), 1062-1073, 1995 | 1040 | 1995 |
| Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial GU Meduri, E Golden, AX Freire, E Taylor, M Zaman, SJ Carson, ... Chest 131 (4), 954-963, 2007 | 991 | 2007 |
| Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial GU Meduri, E Golden, AX Freire, E Taylor, M Zaman, SJ Carson, ... Chest 131 (4), 954-963, 2007 | 991 | 2007 |
| Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study M Confalonieri, R Urbino, A Potena, M Piattella, P Parigi, G Puccio, ... American journal of respiratory and critical care medicine 171 (3), 242-248, 2005 | 917 | 2005 |
| Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy GU Meduri, D Annane, GP Chrousos, PE Marik, SE Sinclair Chest 136 (6), 1631-1643, 2009 | 293 | 2009 |
| Society of Critical Care Medicine’s international consensus conference on prediction and identification of long-term impairments after critical illness ME Mikkelsen, M Still, BJ Anderson, OJ Bienvenu, MB Brodsky, ... Critical care medicine 48 (11), 1670-1679, 2020 | 218 | 2020 |
| H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment AM Quispe-Laime, JD Bracco, PA Barberio, CG Campagne, VE Rolfo, ... Intensive care medicine 36, 33-41, 2010 | 207 | 2010 |
| Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia F Salton, P Confalonieri, GU Meduri, P Santus, S Harari, R Scala, S Lanini, ... Open forum infectious diseases 7 (10), ofaa421, 2020 | 161 | 2020 |
| Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia GU Meduri, MC Shih, L Bridges, TJ Martin, A El-Solh, N Seam, ... Intensive care medicine 48 (8), 1009-1023, 2022 | 98 | 2022 |
| The effect of physical activity on PTSD LM Oppizzi, R Umberger Issues in mental health nursing 39 (2), 179-187, 2018 | 77 | 2018 |
| Severe sepsis in older adults R Umberger, B Callen, ML Brown Critical Care Nursing Quarterly 38 (3), 259-270, 2015 | 32 | 2015 |
| Understanding negative predictive value of diagnostic tests used in clinical practice RA Umberger, LA Hatfield, PM Speck Dimensions of critical care nursing 36 (1), 22-29, 2017 | 30 | 2017 |
| Prolonged methylprednisolone treatment improves lung function and outcome of unresolving ARDS. A randomized, double-blind, placebo-controlled trial GU Meduri, S Headley, S Carson, R Umberger, T Kelso, E Tolley JAMA 280 (2), 159-165, 1998 | 30 | 1998 |
| Review of best practices for CLABSI prevention and the impact of recent legislation on CLABSI reporting B Woodward, R Umberger Sage Open 6 (4), 2158244016677747, 2016 | 27 | 2016 |
| Nursing genomics: practice implications every nurse should know R Umberger, EC Holston, SP Hutson, M Pierce Nursing Clinics 48 (4), 499-522, 2013 | 27 | 2013 |
| Methylprednisolone for unresolving ARDS A Wheeler, GR Bernard, D Schoenfeld, K Steinberg JAMA 280 (24), 2074-2074, 1998 | 27 | 1998 |
| Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement QUA Nawab, E Golden, M Confalonieri, R Umberger, G Umberto Meduri Intensive care medicine 37, 1553-1554, 2011 | 26 | 2011 |
| Survivor but not fully recovered: the lived experience after 1 year of surviving sepsis RA Umberger, SP Thomas Dimensions of Critical Care Nursing 38 (6), 317-327, 2019 | 22 | 2019 |
| Inter‐individual variability of plasma PAF‐acetylhydrolase activity in ARDS patients and PAFAH genotype S Li, L Stuart, Y Zhang, GU Meduri, R Umberger, CR Yates Journal of clinical pharmacy and therapeutics 34 (4), 447-455, 2009 | 22 | 2009 |
